Lactulose

CLINICAL USE

Constipation Hepatic encephalopathy

DOSE IN NORMAL RENAL FUNCTION

Constipation: initially 15 mL twice daily; adjust according to requirementsHepatic encephalopathy: 30–50 mL 3 times daily adjusted to produce 2–3 soft stools daily

PHARMACOKINETICS

Molecular weight :342.3

%Protein binding :No data

%Excreted unchanged in urine : <3

Volume of distribution (L/kg) :N/A – not absorbed

half-life – normal/ESRD (hrs) :No data

DOSE IN RENAL IMPAIRMENT

GFR (mL/MIN)

20 to 50 : Dose as in normal renal function

10 to 20 : Dose as in normal renal function

<10 : Dose as in normal renal function

DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

CAPD :Not dialysed. Dose as in normal renal function

HD :Not dialysed. Dose as in normal renal function

HDF/high flux :Not dialysed. Dose as in normal renal function

CAV/VVHD :Not dialysed. Dose as in normal renal function

IMPORTANT DRUG INTERACTIONS

Potentially hazardous interactions with other drugs

None known

ADMINISTRATION

Reconstition

–

Route

Oral

Rate of Administration

–

Comments

–

OTHER INFORMATION

May take up to 72 hours to work Not significantly absorbed from GIT Safe for diabetics (lactulose is converted to lactic, formic and acetic acid in the bowel)Osmotic and bulking effect

See how to identify renal failure stages according to GFR calculation

See how to diagnose irreversible renal disease

Home